ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials For The Month of June

June 24, 2011

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

In Brief: Pass Joins Karmanos Cancer Institute; Nag President-Elect, Brachytherapy Society

June 27, 1997

In Brief: Antman, Chabner Vie For ASCO President-Elect; Irwin Krakoff Is 1993 Karnofsky Lecturer

January 8, 1993

Plaza Dedicated At NIH In Honor Of Paul Rogers.

June 15, 2001